Survival after relapse in childhood acute lymphoblastic leukemia: Impact of site and time to first relapse - The Children's Cancer Group experience

Cancer

Volumn 82, Issue 7, 1998, Pages 1387-1395

  Gaynon, Paul S ^a,f   Qu, Roger P ^a   Chappell, Richard J ^a   Willoughby, Michael L N ^b   Tubergen, David G ^c   Steinherz, Peter G ^d   Trigg, Michael E ^e  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f NONE   (United States)

Author keywords

Acute lymphoblastic leukemia; Combined relapse; Isolated relapse; Second adverse event

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CHILDHOOD CANCER; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RECURRENCE; SURVIVAL RATE; TESTICULAR NEOPLASMS;

EID: 0032055521     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1     Document Type: Article

References (32)

1. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States: sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995;75: 2186-95.
2. Miller RW, Young JL, Novakovic B. Childhood cancer. Cancer 1995;75:395-405.
3. Buchanan GR, Boyett JM, Rivera GK. Intensive continuation therapy for children with acute lymphoblastic leukemia (ALL) in second marrow remission: a Pediatric Oncology Group (POG) study [abstract 727]. Proc Am Soc Clin Oncol 1988;7:188.
4. Bleyer WA, Sather H, Hammond GD. Prognosis and treatment after relapse of acute lymphoblastic leukemia and non-Hodgkin's lymphoma: 1985. A report from the Children's Cancer Study Group. Cancer 1986;58:590-4.
5. Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, et al. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Children's Cancer Group Phase III trial. J Clin Oncol 1993;11:527-37.
6. Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, et al. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Children's Cancer Group report. J Clin Oncol 1993;11:520-6.
7. Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finklestein JZ, et al. Intensive therapy for children with acute lymphoblastic leukemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Children's Cancer Study Group. Lancet 1988;2:921-4.
8. Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finklestein JZ, et al. Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of Children's Cancer Group study CCG-106. J Clin Oncol 1993;11:2234-42.
9. Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, et al. Cytoreduction and prognosis in acute lymphoblastic leukemia - the importance of early marrow response: report from the Children's Cancer Group. J Clin Oncol 1996;14:389-98.
10. Lange BJ, Blatt J, Sather HN, Meadows AT. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Children's Cancer Group study. Med Pediatr Oncol 1996;27:15-20.
11. Finklestein JZ, Miller DR, Feusner J, Stram DO, Baum E, Shina DC, et al. Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. Cancer 1994;73:219-23.
12. Feig SA, Ames MM, Sather HN, Steinherz L, Reid JM, Trigg M, et al. Comparison of Idarubicin to daunomycin in a randomized multi-drug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group. Med Pediatr Oncol. In press.
13. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chron Dis 1958;8:699-712.
14. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley and Sons, 1980.
15. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. analysis and examples. Br J Cancer 1977;35:1-39.
16. Venables WN, Ripley BD. Modern Applied Statistics with S-Plus. New York: Springer-Verlag, 1994.
17. Gustafsson G, Kreuger A. Prognosis after relapse in acute lymphoblastic leukemia in childhood. Pediatr Hematol Oncol 1986;3:119-26.
18. Henze G, Fengler R, Harman NR, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 1991;78: 1166-72.
19. Barren AJ, Horowitz MM, Pollock BH, Zhang M-J, Bortin MM, Buchanan GR, et al. Bone marrow transplants form HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994;331:1253-8.
20. Sadowitz PD, Smith SD, Shuster J, Wharam MD, Buchanan GR, and Rivera GK: Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1993;81:602-9.
21. Pinkel D. Allogeneic bone marrow transplantation in children with acute leukemia: a practice whose time has gone. Leukemia 1989;3:242-4.
22. Borgmann A, Hartmann R, Schmid H, Klingebiel T, Ebell W, Göbel U, et al. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. Bone Marrow Transpl 1995;15:515-21.
23. Bührer C, Hartmann R, Fengler R, Dopfer R, Gadner H, Gerein V, et al. Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1993;21:470-6.
24. Pui CH, Dodge RK, Look AT, George SL, Rivera GK, Abromowitch M, et al. Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude total therapy studies VIII, IX, and X. J Clin Oncol 1991;9: 1341-7.
25. Gaynon PS, Bostrom BC, Reaman GH, Sather HN, Trigg ME, Tubergen DG, Uckun FM: Mechanisms of treatment failure in childhood acute lymphoblastic leukemia: Children's Cancer Study Group Initiatives. In: Büchner T, Schellong G, Hiddemann W, Urbanitz D, Ritter J, editors. Acute Leukemas VI: Prognostic Factors and Treatment Strategies. Berlin: Springer-Verlag, 1997:611-28.
26. Winick NJ, Smith SD, Shuster J, Lauer S, Wharam MD, Land V, et al. Treatment of CNS relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1993;11:271-8.
27. Ritchey AK, Pollock BH, Lauer S, Homans A, Newman E, Andejeski Y, et al. Delayed craniospinal irradiation (CS RT) with intensified chemotherapy for isolated meningeal relapse of childhood acute lymphoblastic leukemia (ALL). Blood 1993;82:195a.
28. Bleyer WA, Poplack DG: Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin Oncol 1985;12:131-48.
29. Uderzo C, Zurlo MG, Adamoli L, Zanesco L, Arico' M, Calculli G, et al. Treatment of isolated testicular relapse in childhood acute lymphoblastic leukemia: an Italian multicenter study. J Clin Oncol 1990;8:672-7.
30. Buchanan GR, Boyett JM, Pollock BH, Smith SD, Yanofsky RA, Ghim T, et al. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute acute lymphoblastic leukemia. A Pediatric Oncology Group study. Cancer 1991;68:48-55.
31. Wofford MM, Smith SD, Shuster JJ, Johnson W, Buchanan GR, Wharam MD, et al. Treatment of occult or late overt testicular relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1992; 10:624-30.
32. Childhood ALL Collaborative Group. Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukemia; overview of 42 trials involving 12,000 randomised children. Lancet 1996;347:1783-8.